Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX 27 12-1 Month Momentum % is -39.23% as of Jul. 25, 2026. GuruFocus rates ASX:CSX with a GF Score™ of 27/100 and a GF Value™ of A$0.55 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 826 Medical Devices & Instruments companies, CleanSpace Holdings ranks worse than 73.73% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-25), CleanSpace Holdings's 12-1 Month Momentum % is -39.23%.
The industry rank for CleanSpace Holdings's 12-1 Month Momentum % or its related term are showing as below:
ASX:CSX's 12-1 Month Momentum % is ranked worse than 73.73% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: -18.05
vs ASX:CSX: -39.23
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
CleanSpace Holdings 12-1 Month Momentum % Related Terms
ASX:CSX vs ABT, SYK, MDT: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, CleanSpace Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -39.23% mean?
CleanSpace Holdings (ASX:CSX) has a 12-1 Month Momentum % of -39.23% as of Jul. 25, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on CleanSpace Holdings and its competitors. According to the industry distribution chart, CleanSpace Holdings ranks #609 out of 826 companies in the Medical Devices & Instruments industry, placing it in the top 73.7%.
Is CleanSpace Holdings' 12-1 Month Momentum % too high?
CleanSpace Holdings' current 12-1 Month Momentum % is -39.23%. Based on the distribution chart, CleanSpace Holdings ranks #609 out of 826 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CleanSpace Holdings has a GF Score™ of 27/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' 12-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #609 out of 826 companies for 12-1 Month Momentum %. This places CleanSpace Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on CleanSpace Holdings and its competitors. CleanSpace Holdings's current 12-1 Month Momentum % is -39.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.55, compared to a current price of A$0.40 — trading 28.2% below its estimated fair value. The current 12-1 Month Momentum % is -39.23%. CleanSpace Holdings' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current 12-1 Month Momentum % is -39.23% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.40 is trading 28.2% below its estimated GF Value™ of A$0.55.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
12-1 Month Momentum %: -39.23%
GF Value™: A$0.55 vs. price of A$0.40 (28.2% below fair value)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
27GF Score
Get the complete analysis for ASX:CSX
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
